1.300USD-3.70%Mkt Cap: 1.35M $P/E: —1d ago
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measureme…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap1.35M $
Enterprise Value-2.18M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-6.85M $
Revenue/Share—
Last Price1.300 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees6
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-4.06
PEG—
EV/EBITDA0.32
EV/Revenue—
P/S—
P/B0.32
EPS (TTM)-3.74
EPS (Forward)-0.32
52W Range
1.0302% of range16.68
52W High16.68 USD
52W Low1.030 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-114.61%
ROA-96.20%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.05M $
CapEx (TTM)173.74K $
FCF Margin—
FCF Yield-303.64%
Net Debt-3.58M $
Net Debt/EBITDA0.52
Balance Sheet
Debt/Equity0.02
Current Ratio2.81
Quick Ratio2.61
Book Value/Sh4.041 USD
Cash/Share3.561 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:4
Split DateJan 29, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.03M
Float879.95K
Insiders6.07%
Institutions13.43%
Short Interest
Short Ratio0.1d
Short % Float46.83%
Short % Out.43.99%
Shares Short455.20K
Short (prev mo.)31.10K
Technical
SMA 502.621 (-50.4%)
SMA 2003.813 (-65.9%)
Beta0.88
S&P 52W Chg20.25%
Avg Vol (30d)7.86M
Avg Vol (10d)15.84M
Technical Indicators
RSI (14)34.3
MACD-0.5633
MACD Signal-0.4647
MACD Hist.-0.0986
BB Upper4.947 USD
BB Middle2.299 USD
BB Lower-0.3499 USD
BB Width230.45%
ATR (14)0.4808 USD
Vol Ratio (20d)0.10x